Clometro 7HP

Per combi pack: 14 Claritrox tab each containing Clarithromycin 250 mg, 14 Metgyl tab each containing Metronidazole 400 mg, 14 Omilock cap each containing Omeprazole 20 mg

Peptic ulcer associated w/ H pylori.

1 tab/cap bd for 1-2 wk.

Should be taken on an empty stomach.

Claritrox Hypersensitivity to other macrolides. Co-administration w/ cisapride, pimozide, terfenadine & ergot derivatives. Metgyl Hypersensitivity to nitroimidazoles. CNS disorders, blood dyscrasias. Concurrent use w/ ethyl alcohol. Severe hepatic failure. 1st trimester of pregnancy & lactation. Omilock Hypersensitivity.

Claritrox Cross-sensitivity or hypersensitivity. Increased risk of Clostridium difficile-associated diarrhea. Discontinue use if superinfection occurs after prolonged use. Hepatic or renal impairment. Pregnancy & lactation. Metgyl Discontinue use if signs of peripheral neuropathy or CNS toxicity develop. Blood dyscrasia or active CNS disease. Long-term use (>10 days). Severe hepatic disease. Not recommended during 1st trimester of pregnancy & lactation. Omilock Gastric malignancy. Chronic hepatic disease. Not recommended during pregnancy. Lactation.

Claritrox Diarrhoea, nausea, abnormal taste, dyspepsia, abdominal pain/discomfort, headache. Metgyl GI disturbances eg, nausea & unpleasant metallic taste; nausea accompanied by headache, anorexia, vomiting. Omilock Abdominal pain or colic.

Claritrox Increased plasma conc of carbamazepine & terfenadine. Increased serum digoxin conc. Decreased serum conc w/ rifabutin or rifampin. Increased AUC of theophylline. Potentiated effects of warfarin. Acute ergot toxicity w/ ergotamine or dihydroergotamine. CNS effects w/ triazolam. Increased serum levels of cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, quinidine/disopyramide, lovastatin, bromocriptine, valproate, astemizole & CYP450-metabolised drugs. Ventricular arrhythmias w/ non-sedative antihistamines eg, astemizole, terfenadine & cisapride. Lowered C_max, AUC & delayed T_max w/ zidovudine. Metgyl Disulfiram-like effects w/ alcohol. Potentiated effects of coumarin- or indandione-derivative anticoagulants. Decreased hepatic metabolism w/ cimetidine. Confusion & psychotic reaction w/ disulfiram. Increased lithium conc. Decreased t_½ & plasma conc w/ phenobarb. Increased plasma conc of phenytoin. Spuriously low values on AST assay. Omilock Increased bioavailability of digoxin. Increased plasma conc of diazepam, phenytoin & warfarin.

Antacids, Antireflux Agents & Antiulcerants

A02BD - Combinations for eradication of Helicobacter pylori ; Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

B